Market Cap: $9.34B
Market Cap: $9.34B
Open
$78.96
Prev. Close
$69.99
High
$80.13
Low
$78.25
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions.
Globus Medical, Inc. trades on the New York Stock Exchange under the ticker GMED, priced in USD.
Globus Medical, Inc. has a market capitalisation of $9.34B, based on its latest share price.
GMED trades at 17.43 times its trailing 12-month earnings.
Over the past 52 weeks GMED has traded between $69.02 and $101.40.
No. Globus Medical, Inc. does not currently pay a dividend.
Highly profitable: keeps 17.8% of revenue as net profit.
The analyst consensus rating for GMED is Buy. Analysts' average 12-month price target of $102.81 implies 46% upside.
Keith W. Pfeil is the CEO of Globus Medical, Inc., which is headquartered in Audubon.
Generated automatically from reported financial data. General information only, not financial advice.
Earnings Reporting Season: Insights into the Medical Device Sector As the earnings reporting season approaches, attention is directed towards companies within the medical device industry, where innova…
Emerging Technological Innovations Drive Future Growth at Globus Medical In light of the current competitive landscape in the medical device industry, Globus Medical, a leader in musculoskeletal solut…
### Earnings Reports: A Reflection of Market Dynamics Globus Medical operates within a dynamic medical device sector, where the trajectory of earnings reports from industry peers provides critical ins…
Globus Medical's Executive Moves Signal Strategic Shifts In a notable development for Globus Medical, Executive Chairman Paul recently liquidates a significant portion of his equity stake by exercisin…